Trials / Completed
CompletedNCT00835952
ATX-101 Abdominoplasty
Phase 1, Open-label Study of the Safety, Tolerability, and Histological Effect of Single Doses of ATX-101 (Sodium Deoxycholate for Injection) Administered in Abdominal Fat in Subjects Undergoing Abdominoplasty
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 14 (estimated)
- Sponsor
- Kythera Biopharmaceuticals · Industry
- Sex
- All
- Age
- 25 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ATX-101 | ATX-101 single doses |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2009-03-01
- Completion
- 2009-04-01
- First posted
- 2009-02-04
- Last updated
- 2010-01-27
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00835952. Inclusion in this directory is not an endorsement.